A Mussagaliyeva
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Lipoproteins and Cardiovascular Health, Antiplatelet Therapy and Cardiovascular Diseases, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk(2019)4,829 cited
- Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))(2019)
- → Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan.(2014)20 cited
- → Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205](2019)15 cited
- → Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205](2019)14 cited
- → Clinical and demographic features of patients with stroke and atrial fibrillation(2018)3 cited
- → Analysis of Relationship Between Parameters of Arterial Stiffness and Lipid Profile in Patients With Metabolic Syndrome(2018)2 cited
- → Prevalence and Major Risk Factors for Atrial Fibrillation(2019)2 cited
- → A Rare Case of Takayasu Arteritis With Total Left Main Coronary Artery Occlusion(2020)1 cited
- → POPULATION FEATURES OF THE GENETIC MARKER’S DISTRIBUTION OF THE HEART FAILURE EFFECTIVENESS THERAPY WITH SGLT2 INHIBITORS IN THE KAZAKH POPULATION(2023)1 cited